RT Journal Article
SR Electronic
T1 Potency and Breadth of Neutralization after 3 doses of mRNA vaccines in COVID-19 Convalescent and Naïve individuals
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.17.22272557
DO 10.1101/2022.03.17.22272557
A1 Joanna Luczkowiak
A1 Gonzalo Rivas
A1 Nuria Labiod
A1 Fátima Lasala
A1 Marta Rolo
A1 Jaime Lora-Tamayo
A1 Mikel Mancheno-Losa
A1 David Rial-Crestelo
A1 Alfredo Pérez-Rivilla
A1 María D. Folgueira
A1 Rafael Delgado
YR 2022
UL http://medrxiv.org/content/early/2022/03/20/2022.03.17.22272557.abstract
AB Third doses of mRNA COVID-19 vaccines induced a significant increase in neutralizing potency and breadth in naïve individuals comparable with convalescents who restored levels after the first two doses. These results suggest a limit to elicit neutralization in the number of stimuli by infection or vaccination with ancestral SARS-CoV-2 sequencesCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by by grants from the Instituto de Investigacin Carlos III, ISCIII, (FIS PI1801007 and PI2100989), by the European Commission Horizon 2020 Framework Programme: Project VIRUSCAN FETPROACT-2016: 731868, Horizon Europe Framework programme: Project EPIC-CROWN-2 ID: 101046084 and by Fundacion Caixa-Health Research (Project StopEbola HR18-00469) to RD. M.M-L holds a clinical research contract Rio Hortega (CM19/00226) from the Instituto de Salud Carlos III, ISCIII (Spanish Ministry of Science, Innovation and Universities)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Comite Etico de Investigacion Medica (IRB) Hospital Universitario 12 de Octubre. Ref CEIm 20/157I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors